Levetiracetam inhibits interleukin-1b inflammatory responses in the hippocampus and piriform cortex of epileptic rats

Levetiracetam (LEV, 2S-(oxo-1-pyrrolidinyl)butanamide, Keppra, UCB Pharma) is a new anti-epileptic drug used to treat certain types of seizures in epilepsy patients. However, the pharmacodynamics of LEV is still controversial. Recently, interleukin-1b (IL-1b) has been reported to involve in epilepti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuroscience letters 2010-03, Vol.471 (2), p.94-99
Hauptverfasser:	Kim, Ji-Eun, Choi, Hui-Chul, Song, Hong-Ki, Jo, Seung-Mook, Kim, Duk-Soo, Choi, Soo-Young, Kim, Yeong-In, Kang, Tae-Cheon
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!